A detailed history of Ckw Financial Group transactions in Novartis Ag stock. As of the latest transaction made, Ckw Financial Group holds 700 shares of NVS stock, worth $72,996. This represents 0.01% of its overall portfolio holdings.

Number of Shares
700
Previous 800 12.5%
Holding current value
$72,996
Previous $85,000 5.88%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $10,613 - $12,089
-100 Reduced 12.5%
700 $80,000
Q4 2023

Jan 26, 2024

SELL
$92.27 - $101.54 $36,908 - $40,616
-400 Reduced 33.33%
800 $80,000
Q3 2022

Nov 10, 2022

SELL
$74.61 - $87.26 $7,461 - $8,726
-100 Reduced 7.69%
1,200 $91,000
Q2 2022

Aug 04, 2022

SELL
$80.52 - $93.75 $32,208 - $37,500
-400 Reduced 23.53%
1,300 $110,000
Q1 2022

Apr 28, 2022

BUY
$80.11 - $90.62 $11,055 - $12,505
138 Added 8.83%
1,700 $149,000
Q4 2021

Feb 09, 2022

SELL
$79.7 - $88.13 $7,970 - $8,813
-100 Reduced 6.02%
1,562 $140,000
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $36,801 - $42,813
450 Added 37.13%
1,662 $136,000
Q2 2021

Aug 05, 2021

BUY
$85.24 - $94.15 $18,070 - $19,959
212 Added 21.2%
1,212 $111,000
Q4 2020

Feb 10, 2021

SELL
$78.07 - $94.43 $19,517 - $23,607
-250 Reduced 20.0%
1,000 $94,000
Q3 2020

Nov 10, 2020

BUY
$82.14 - $91.0 $8,214 - $9,100
100 Added 8.7%
1,250 $109,000
Q2 2020

Aug 12, 2020

SELL
$80.93 - $91.1 $16,186 - $18,220
-200 Reduced 14.81%
1,150 $101,000
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $12,831 - $14,139
-150 Reduced 10.0%
1,350 $116,000
Q2 2019

Aug 12, 2019

SELL
$75.4 - $92.8 $15,080 - $18,560
-200 Reduced 11.76%
1,500 $137,000
Q4 2018

Jan 16, 2019

SELL
$73.66 - $82.02 $14,732 - $16,404
-200 Reduced 10.53%
1,700 $146,000
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $140,866 - $146,813
1,900
1,900 $163,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ckw Financial Group Portfolio

Follow Ckw Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ckw Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Ckw Financial Group with notifications on news.